Berenberg analyst Tom Jones lowered the firm’s price target on Smith & Nephew to 1,450 GBp from 1,500 GBp and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SNN:
- Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report
- Smith & Nephew announces results for its REGENETEN Bioinductive Implant
- New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
- Smith & Nephew price target raised to 1,380 GBp from 1,360 GBp at Morgan Stanley
- Smith & Nephew assumed with a Buy at Jefferies
